Clinical Trials
We make promising new treatments available to you through studies called clinical trials led by Fred Hutchinson Cancer Center doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally.
The RAVCAR Study
Complete title: Rabies Vaccination to Assess Vaccine Responsiveness after B Cell Targeted CAR-T Cell Therapies
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: I
CARIsMa
Complete title: Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: II
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Complete title: An Open-Label Study to Assess the Safety and Efficacy of Remdesivir for Treatment of Symptomatic Laboratory-Confirmed Respiratory Syncytial Virus Infection of the Upper Respiratory Tract in Patients Receiving Cellular or Bispecific Antibody Therapies
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: II
GeoVax
Complete Title: A Phase 2 randomized, multi-center study of GEO-CMO4S1 (SARS-CoV-2 vaccine) versus mRNA SARS-CoV-2 vaccine in patients post cellular therapy for hematological malignancies
PRINCIPAL INVESTIGATOR: JOSHUA HILL | PHASE: II
© 2025 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.